Radical pancreatic cancer surgery-with arterial resection
- PMID: 30976711
- PMCID: PMC6414335
- DOI: 10.21037/tgh.2019.01.07
Radical pancreatic cancer surgery-with arterial resection
Abstract
Extended surgery with arterial resection in pancreatic cancer remains a controversial topic. Although not recommended as a standard procedure, arterial resection may be feasible in selected patients and with the availability of new multimodal treatment approaches it may gain increasing impact in pancreatic cancer therapy as a complete tumor removal is still the only opportunity to achieve long-term survival for this disease. With regard to the surgical approach, one must differentiate between resection and reconstruction of the celiac axis and the hepatic artery as its most important branch, and resection/reconstruction of the superior mesenteric artery. Both procedures are technically possible and require a distinct level of surgical experience as well as interdisciplinary management for preoperative diagnosis and treatment of postoperative complications to achieve good outcomes. Besides arterial resection followed by reconstruction, there are specific situations when arteries may be resected without reconstruction, e.g., during distal pancreatectomy with celiac axis resection. In addition, in some cases arterial resections can be avoided despite a suspected tumor attachment by sharp dissection on the adventitial layer of the respective artery, especially after neoadjuvant therapy which is increasingly performed for borderline resectable and locally advanced tumor findings. This review summarizes definitions, diagnostics, technical aspects and outcomes of arterial resection in pancreatic cancer surgery in the context of the current literature and evidence.
Keywords: Arterial resection; locally advanced pancreatic cancer; pancreatic surgery.
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Similar articles
-
Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019.Front Oncol. 2020 Feb 4;10:40. doi: 10.3389/fonc.2020.00040. eCollection 2020. Front Oncol. 2020. PMID: 32117714 Free PMC article. Review.
-
Periarterial and Sub-adventitial Divestment Along with Triangle Operation and RAMPS for Pancreatic Body Cancer.Ann Surg Oncol. 2024 Jul;31(7):4688-4690. doi: 10.1245/s10434-024-15303-y. Epub 2024 May 7. Ann Surg Oncol. 2024. PMID: 38714624
-
Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients.J Visc Surg. 2016 Jun;153(3):173-81. doi: 10.1016/j.jviscsurg.2015.11.014. Epub 2016 Jan 13. J Visc Surg. 2016. PMID: 26775202
-
Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement.Langenbecks Arch Surg. 2016 Dec;401(8):1131-1142. doi: 10.1007/s00423-016-1488-y. Epub 2016 Jul 30. Langenbecks Arch Surg. 2016. PMID: 27476146
-
Surgical treatment for advanced pancreatic cancer.Korean J Hepatobiliary Pancreat Surg. 2012 Aug;16(3):89-92. doi: 10.14701/kjhbps.2012.16.3.89. Epub 2012 Aug 31. Korean J Hepatobiliary Pancreat Surg. 2012. PMID: 26388914 Free PMC article. Review.
Cited by
-
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?Langenbecks Arch Surg. 2020 Nov;405(7):879-887. doi: 10.1007/s00423-020-01946-4. Epub 2020 Aug 10. Langenbecks Arch Surg. 2020. PMID: 32776259 Free PMC article. Review.
-
Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019.Front Oncol. 2020 Feb 4;10:40. doi: 10.3389/fonc.2020.00040. eCollection 2020. Front Oncol. 2020. PMID: 32117714 Free PMC article. Review.
-
Surgical management of pancreatic ductal adenocarcinoma: a narrative review.Transl Gastroenterol Hepatol. 2023 Sep 7;8:39. doi: 10.21037/tgh-23-27. eCollection 2023. Transl Gastroenterol Hepatol. 2023. PMID: 38021357 Free PMC article. Review.
-
Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)-basis and current status.Ecancermedicalscience. 2022 Mar 24;16:1367. doi: 10.3332/ecancer.2022.1367. eCollection 2022. Ecancermedicalscience. 2022. PMID: 35685956 Free PMC article. Review.
-
[Definition and treatment of superior mesenteric artery revascularization and dissection-associated diarrhea (SMARD syndrome) in Germany].Chirurg. 2022 Feb;93(2):173-181. doi: 10.1007/s00104-021-01427-4. Epub 2021 Jun 8. Chirurg. 2022. PMID: 34100984 Free PMC article. Review. German.
References
-
- Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet 2017;389:1011-24. 10.1016/S0140-6736(16)32409-6 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources